Europe — EMA
Octaplaslg (Human Plasma Protein)
Human Plasma Protein, the active ingredient in Octaplaslg, is a plasma‑derived protein concentrate presented as an intravenous solution for IV use.
Request sourcing
What is Human Plasma Protein?
Human Plasma Protein, the active ingredient in Octaplaslg, is a plasma‑derived protein concentrate presented as an intravenous solution for IV use. It provides coagulation factor replacement in patients with bleeding disorders or undergoing major surgery. GNH USA supplies Octaplaslg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
GNH USA supplies Octaplaslg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Human Plasma Protein used for?
Octaplaslg is a plasma‑derived hemostatic agent used in clinical situations that require rapid restoration of multiple clotting factors.
- Massive transfusion protocols: helps re‑establish hemostasis during massive blood loss. - Liver transplantation: provides balanced clotting factors to support graft function. - Congenital coagulation factor deficiencies: supplies missing factors for patients with rare bleeding disorders. - Cardiac surgery with cardiopulmonary bypass: assists in maintaining coagulation balance. - Trauma‑induced coagulopathy: aids in correcting coagulopathy after severe injury.
What are the side effects of Human Plasma Protein?
Adverse reactions to Octaplaslg are generally related to its plasma origin and infusion process.
Common Side Effects: - Mild fever - Headache - Nausea - Transient hypotension - Chills - Flushing
Serious or Rare Side Effects: - Anaphylactic reaction - Severe transfusion‑related acute lung injury (TRALI) - Severe allergic urtic uric - Volume overload leading to pulmonary edema - Hemolytic transfusion reaction - Disseminated intravascular coagulation (DIII ).
What precautions apply to Human Plasma Protein?
When using Octaplaslg, clinicians should observe several safety measures.
- Verify patient identity and blood type: ensure compatibility before infusion. - Monitor vital signs: watch for changes in blood pressure, heart rate, and oxygen saturation during and after administration. - Assess for prior plasma reactions: review patient history for allergic or transfusion reactions. - Use aseptic technique: maintain sterility of the infusion set and catheter. - Adjust infusion rate: follow institutional protocols to minimize adverse events. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Plasma Protein interact with?
Octapicos g g .
Major g . - g. - ullet . -
t .
